Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 399.037 million compared to CNY 235.614 million a year ago. Operating income was CNY 68.518 million compared to CNY 27.703 million a year ago. Net income was CNY 65.485 million compared to CNY 29.078 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.03 a year ago.